Skip to main content

Plasma therapy test trials continue

By Abdul Qadir Qureshi
(Pakistan News & Features Services)

A new clinical trial evaluating the efficacy and safety of plasma therapy, an emerging form of treatment for the coronavirus, in Pakistani COVID-19 patients is underway at the Aga Khan University (AKU) in Karachi. 

Convalescent plasma therapy involves separating blood donated by previous COVID-19 patients into plasma, a clear straw-coloured liquid, that contains antibodies and proteins that help fight infections. 

The plasma is then injected into a severely ill COVID-19 patient whose immune system may not be able to generate the antibodies needed to combat the virus. A single donation can potentially treat two patients.

There is currently no vaccine for the coronavirus and no approved form of treatment beyond managing its symptoms. The trial will generate evidence on whether plasma therapy, the only experimental treatment currently available for the virus, can help treat those suffering from acute complications from the virus. 

The researchers will perform three pre-procedural investigations on each donor to ensure their blood is safe from other infections and to check their suitability for the process of apheresis which collects plasma. 

Like a typical blood donation, the process is painless after the initial prick and lasts approximately two hours. Once plasma is transfused into a patient, the team will monitor the response to the treatment and assess its effectiveness through clinical and laboratory tests. Informed consent will be sought from all potential donors as well as those receiving the treatment. 

“Plasma therapy can potentially help treat patients with moderate to severe COVID-19 infection,” Dr Natasha Ali, who is part of a team of six faculty members from the departments of Pathology and Laboratory Medicine, and Internal Medicine, working on the trial, remarked.

“This trial is part of the University’s science-based approach to evaluating novel treatments that can help save lives during this pandemic,” she added. 

The AKU is also participating in Solidarity, the international clinical trial launched by the World Health Organization (WHO) and its partners, to find effective treatments for the coronavirus. 

The study has been approved by the Drug Regulatory Authority of Pakistan and Pakistan’s National Bioethics Committee.
Labels:

Comments

Post a Comment

Popular posts from this blog

Ambassador explains Chinese role in curbing COVID-19

By Masood Sattar Khan  (Pakistan News & Features Services) The Chinese Ambassador to Pakistan, Yao Jing, attended the preparation and response plan of the new crown epidemic on April 24. According to the details shared by the Chinese Embassy in Islamabad, Ambassador Yao Jing was invited to attend the Pakistan New Crown Outbreak Preparation and Response Plan (PPRP) on video conference. The meeting, organized by the Pakistani Ministry of Foreign Affairs, was also attended by Foreign Minister Shah Mahmood Qureshi, Minister of Economic Affairs, Khasro Bakhtiar, Prime Minister’s Health Adviser Dr Zafar Mirza, Chairman of the National Disaster Management Authority, General Muhammad Afzal, WHO Director-General, Tan Desai besides the representatives of World Bank, United Nations, UNICEF, UNHCR, Asian Development Bank, Islamic Development Bank and envoys from more than 20 countries.  Besides China, envoys from the United States, the United Kingdom, France, Canada, the European Unio...
Post a Comment
Read more

Corona field facility at Karachi Expo Centre may admit patients now

By Mukhtar Alam (Pakistan News & Features Services) The 1,200-bed field isolation centre at the Karachi Expo Centre, on April 6, will open its doors for new COVID-19 infected patients of Karachi and other parts of Sindh who will be referred to it by designated tertiary care hospitals, as the diseases infected another 51 people in six districts of Sindh on April 5.  A source in the provincial health department informed PNFS that authorities have decided not to overburden the designated tertiary care health facilities in terms of corona cases further.  The hospitals have now been asked to admit only new severely ill COVID-19 patients or those seeking intensive cares, while the rest will present at the newly established Expo Centre isolation facility, where the Sindh health department has deployed its doctors, paramedics and other human resources, the source added. Through a letter of the health department, all the district health officers of Karachi division have been asked ...
Post a Comment
Read more

Khumar Farooqui passes away

By Abdul Qadir Qureshi (Pakistan News & Features Services) Noted poet and writer, Masroor Alam Farooqui, famously known as Khumar Farooqui, passed away in Karachi after a brief illness. He was 71. He has left behind a widow, two sons and two daughters besides grandsons and granddaughters to mourn his death. Khumar Farooqui was born at Agra, British India, in 1942. Upon migration to Pakistan, he did his MA and LL.B from Rawalpindi. He joined government service at the Federal Bureau of Statistics from where he retired as the Chief Statistical Officer. A born poet, Khumar Farooqui joined the Sir Syed University of Engineering & Technology (SSUET), Karachi, as a consultant and worked in its Literary and Cultural Forum headed by Late Brig (Rtd) Qamarussalam after whose death he became the convener of the forum. He used to attend mushairas at national and international levels. His poetry ...
Post a Comment
Read more